• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用于治疗炎症性肠病的结肠靶向给药系统的设计策略、进展及未来展望。

Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease.

作者信息

Zheng Baoxin, Wang Liping, Yi Yan, Yin Jun, Liang Aihua

机构信息

Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

School of Traditional Chinese Material, Shenyang Pharmaceutical University, Shenyang 110016, China.

出版信息

Asian J Pharm Sci. 2024 Aug;19(4):100943. doi: 10.1016/j.ajps.2024.100943. Epub 2024 Jul 14.

DOI:10.1016/j.ajps.2024.100943
PMID:39246510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11375318/
Abstract

Inflammatory bowel diseases (IBD) significantly contribute to high mortality globally and negatively affect patients' qualifications of life. The gastrointestinal tract has unique anatomical characteristics and physiological environment limitations. Moreover, certain natural or synthetic anti-inflammatory drugs are associated with poor targeting, low drug accumulation at the lesion site, and other side effects, hindering them from exerting their therapeutic effects. Colon-targeted drug delivery systems represent attractive alternatives as novel carriers for IBD treatment. This review mainly discusses the treatment status of IBD, obstacles to drug delivery, design strategies of colon-targeted delivery systems, and perspectives on the existing complementary therapies. Moreover, based on recent reports, we summarized the therapeutic mechanism of colon-targeted drug delivery. Finally, we addressed the challenges and future directions to facilitate the exploitation of advanced nanomedicine for IBD therapy.

摘要

炎症性肠病（IBD）在全球范围内显著导致高死亡率，并对患者的生活质量产生负面影响。胃肠道具有独特的解剖学特征和生理环境限制。此外，某些天然或合成抗炎药物存在靶向性差、病变部位药物蓄积低以及其他副作用等问题，阻碍了它们发挥治疗作用。结肠靶向给药系统作为IBD治疗的新型载体，是有吸引力的替代方案。本综述主要讨论了IBD的治疗现状、药物递送的障碍、结肠靶向递送系统的设计策略以及现有辅助疗法的前景。此外，基于近期报道，我们总结了结肠靶向给药的治疗机制。最后，我们阐述了挑战和未来方向，以促进先进纳米药物在IBD治疗中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/d5e80491c5a3/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/e250eacc146b/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/a8afe2221357/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/65c7d8cea276/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/f68186924b6d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/e9002129c900/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/9fabecb8b15a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/8446dc89b214/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/b9b09cf7f9ae/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/4b8610d1b13d/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/7ab0fa867aec/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/79c38c0f27b2/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/2e5ceca41b92/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/d5e80491c5a3/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/e250eacc146b/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/a8afe2221357/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/65c7d8cea276/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/f68186924b6d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/e9002129c900/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/9fabecb8b15a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/8446dc89b214/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/b9b09cf7f9ae/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/4b8610d1b13d/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/7ab0fa867aec/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/79c38c0f27b2/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/2e5ceca41b92/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d952/11375318/d5e80491c5a3/gr12.jpg

相似文献

1
Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease.用于治疗炎症性肠病的结肠靶向给药系统的设计策略、进展及未来展望。
Asian J Pharm Sci. 2024 Aug;19(4):100943. doi: 10.1016/j.ajps.2024.100943. Epub 2024 Jul 14.
2
Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease.用于治疗炎症性肠病的靶向炎症的纳米颗粒药物递送系统。
Nano Today. 2017 Oct;16:82-96. doi: 10.1016/j.nantod.2017.08.006. Epub 2017 Oct 9.
3
Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances.口服纳米医学系统靶向结肠炎症治疗炎症性肠病：最新进展。
J Mater Chem B. 2023 Dec 22;12(1):13-38. doi: 10.1039/d3tb02302h.
4
Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.用于炎症性肠病结肠靶向给药的口服纳米给药系统进展：对病变组织与健康组织的选择性靶向
Nanomedicine. 2015 Jul;11(5):1117-32. doi: 10.1016/j.nano.2015.02.018. Epub 2015 Mar 14.
5
Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives.基于天然多糖的口服微纳米给药系统治疗肠道疾病：挑战、进展与未来展望。
J Control Release. 2021 Jun 10;334:353-366. doi: 10.1016/j.jconrel.2021.04.026. Epub 2021 Apr 24.
6
Advances in carbohydrate-based nanoparticles for targeted therapy of inflammatory bowel diseases: A review.基于碳水化合物的纳米颗粒在炎症性肠病靶向治疗中的研究进展：综述
Int J Biol Macromol. 2024 Nov;281(Pt 4):136392. doi: 10.1016/j.ijbiomac.2024.136392. Epub 2024 Oct 16.
7
Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: A review.基于多糖的纳米载体的结肠靶向药物传递用于炎症性肠病的协同治疗：综述。
Carbohydr Polym. 2021 Nov 15;272:118530. doi: 10.1016/j.carbpol.2021.118530. Epub 2021 Aug 4.
8
Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease.用于口服递送的纳米颗粒：炎症性肠病的靶向治疗。
J Mater Chem B. 2022 Aug 10;10(31):5853-5872. doi: 10.1039/d2tb01190e.
9
Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.纳米颗粒介导的药物传递系统治疗炎症性肠病：当前的观点。
Int J Nanomedicine. 2019 Nov 13;14:8875-8889. doi: 10.2147/IJN.S210315. eCollection 2019.
10
Pharmaceutical approaches to colon targeted drug delivery systems.结肠靶向给药系统的药物学方法。
J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66.

引用本文的文献

1
Advanced oral drug delivery systems for gastrointestinal targeted delivery: the design principles and foundations.用于胃肠道靶向给药的先进口服药物递送系统：设计原则与基础
J Nanobiotechnology. 2025 May 30;23(1):400. doi: 10.1186/s12951-025-03479-8.
2
Oral dosage forms for drug delivery to the colon: an existing gap between research and commercial applications.用于结肠给药的口服剂型：研究与商业应用之间的现有差距。
J Mater Sci Mater Med. 2025 Mar 5;36(1):24. doi: 10.1007/s10856-025-06868-5.
3
pH-Dependent Drug Delivery Systems for Ulcerative Colitis Treatment.

本文引用的文献

1
Glucocorticoids-based prodrug design: Current strategies and research progress.基于糖皮质激素的前药设计：当前策略与研究进展
Asian J Pharm Sci. 2024 Jun;19(3):100922. doi: 10.1016/j.ajps.2024.100922. Epub 2024 Apr 24.
2
The landscape of small-molecule prodrugs.小分子前药的领域。
Nat Rev Drug Discov. 2024 May;23(5):365-380. doi: 10.1038/s41573-024-00914-7. Epub 2024 Apr 2.
3
Strategies for targeting cytokines in inflammatory bowel disease.靶向细胞因子治疗炎症性肠病的策略。
用于溃疡性结肠炎治疗的pH依赖性药物递送系统。
Pharmaceutics. 2025 Feb 10;17(2):226. doi: 10.3390/pharmaceutics17020226.
Nat Rev Immunol. 2024 Aug;24(8):559-576. doi: 10.1038/s41577-024-01008-6. Epub 2024 Mar 14.
4
Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment.纳米技术在防治感染性和炎症性疾病方面的前沿应用：预防与治疗。
Signal Transduct Target Ther. 2024 Feb 21;9(1):34. doi: 10.1038/s41392-024-01745-z.
5
Mucoadhesive and thermosensitive Bletilla striata polysaccharide/chitosan hydrogel loaded nanoparticles for rectal drug delivery in ulcerative colitis.载有白及多糖/壳聚糖水凝胶纳米粒的黏膜黏附性和温敏性直肠给药系统用于溃疡性结肠炎治疗。
Int J Biol Macromol. 2024 Jan;254(Pt 1):127761. doi: 10.1016/j.ijbiomac.2023.127761. Epub 2023 Oct 30.
6
Silicon-containing nanomedicine and biomaterials: materials chemistry, multi-dimensional design, and biomedical application.含硅纳米医药与生物材料：材料化学、多维设计与生物医学应用。
Chem Soc Rev. 2024 Feb 5;53(3):1167-1315. doi: 10.1039/d1cs01022k.
7
Starch-Based Hydrogels as a Drug Delivery System in Biomedical Applications.基于淀粉的水凝胶作为生物医学应用中的药物递送系统。
Gels. 2023 Dec 4;9(12):951. doi: 10.3390/gels9120951.
8
3D-printed prednisolone phosphate suppositories with tunable dose and rapid release for the treatment of inflammatory bowel disease.3D 打印的磷酸泼尼松龙栓剂，具有可调节剂量和快速释放的特点，可用于治疗炎症性肠病。
Int J Pharm. 2024 Jan 5;649:123639. doi: 10.1016/j.ijpharm.2023.123639. Epub 2023 Nov 30.
9
Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in Colitis.通过调节结肠炎氧化应激水平口服给药用于治疗炎症性肠病的结肠靶向纳米治疗剂
ACS Nano. 2023 Dec 12;17(23):24404-24416. doi: 10.1021/acsnano.3c11089. Epub 2023 Dec 1.
10
Triggerable Prodrug Nanocoating Enables On-Demand Activation of Microbial and Small-Molecular Therapeutics for Combination Treatment.触发型前药纳米涂层可实现微生物和小分子治疗药物的按需激活，用于联合治疗。
J Am Chem Soc. 2023 Dec 13;145(49):26932-26946. doi: 10.1021/jacs.3c10015. Epub 2023 Nov 21.